REFERENCES

1. Carpio A, Fleury A, Hauser WA. Neurocysticercosis: five new things. Neurol Clin Pract 2013;3:118-25.

2. Del Brutto OH. Neurocysticercosis. Continuum (Minneap Minn) 2012;18:1392-416.

3. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 2011;9:123-33.

4. Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-62.

5. Das RR, Tekulve KJ, Agarwal A, Tormoehlen LM. Racemose neurocysticercosis. Semin Neurol 2012;32:550-5.

6. Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 2010;104:243-50.

7. Garcia HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, Rajshekhar V, Tsang VC, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez AE, Gilman RH, Del Brutto OH. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15:747-56.

8. Wu W, Jia F, Wang W, Huang Y, Huang Y. Antiparasitic treatment of cerebral cysticercosis: lessons and experiences from China. Parasitol Res 2013;112:2879-90.

9. Carpio A. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry 1999;66:411-2.

10. Torres-Corzo JG, Tapia-Perez JH, Vecchia RR, Chalita-Williams JC, Sanchez-Aguilar M, Sanchez-Rodriguez JJ. Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg 2010;112:11-6.